About Inflammatory Breast Cancer
Inflammatory Breast Cancer (IBC) is a rare and aggressive form of breast cancer. The exact causes of IBC are not fully understood, but research suggests that it may involve a combination of genetic, hormonal, and environmental factors.
Non-modifiable risk factors are risk factors that cannot be changed. The non-modifiable risk factors associated with IBC include:
- Gender: IBC primarily affects women, although men can also develop it.
- Age: IBC tends to occur at a younger age.
- Race: African American women have a higher risk of developing IBC compared to women of other races.
- Genetics: Certain gene mutations, such as BRCA1 and BRCA2, can increase the risk of developing IBC.
- Family history of breast cancer
Modifiable risk factors are risk factors that can be changed or influenced. Modifiable risk factors that may contribute to the development of IBC include:
- Obesity
- Long-term use of hormone replacement therapy (HRT) or oral contraceptives
- Heavy alcohol consumption
It's important to note that while these factors may increase the likelihood of developing IBC, they do not guarantee its occurrence. Regular breast self-exams, mammograms, and consultations with healthcare professionals are crucial for early detection and appropriate management.
The most common early symptoms of IBC include:
- Redness, swelling, and thickening of the skin of the breast
- Itching and heaviness in the breast
- Swelling of the breast
- Inverted or retracted nipple
As IBC progresses or reaches higher severity, additional symptoms may occur, such as:
- Breast skin that is pitted or dimpled
- Increase in breast size
- Warmth and tenderness in the breast
- Pain in the breast or surrounding area
- Swollen lymph nodes
It's important to note that IBC symptoms are usually more prominent and severe compared to other types of breast cancer. If you experience any changes in your breast tissue or notice any of these symptoms, it's crucial to see a doctor for further evaluation. Remember, early detection and timely treatment can make a significant difference in managing IBC.
To diagnose inflammatory breast cancer, the following examinations, tests, and procedures are commonly performed:
- Biopsy: A doctor removes tissue from the breast to examine for signs of cancer.
- Imaging studies: These tests help visualize the breast and surrounding areas to detect cancer and determine its extent. Common imaging studies include mammograms, ultrasounds, MRI scans, CT scans, or bone scans.
It's important to consult with a doctor who specializes in this disease for proper diagnosis, staging, and treatment planning.
The goals of treatment for inflammatory breast cancer (IBC) are to eliminate or control the cancer, prevent its recurrence, and improve survival rates. Treatment may include:
- Chemotherapy: This treatment involves the use of drugs to shrink the tumor before surgery.
- Surgery: The standard surgical procedure for IBC is a modified radical mastectomy. This involves removing the entire affected breast, most or all of the lymph nodes under the adjacent arm, and sometimes the lining over the underlying chest muscles.
- Radiation therapy: Post-surgery radiation therapy targets any remaining cancer cells in the chest wall under the removed breast and helps reduce the risk of recurrence.
- Targeted therapy: Inflammatory breast cancers often produce an excess of HER2 protein. Specific drugs can target this protein and are used to improve treatment outcomes.
- Health behavior changes: Maintaining a healthy lifestyle, including regular exercise, a balanced diet, and avoiding tobacco and excessive alcohol consumption, can support overall well-being during treatment.
Always consult with your healthcare professional for personalized advice regarding treatment options for IBC. Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.